THE BODY MASS INDEX INFLUENCES THE ACHIEVEMENT RATIO OF TARGET BLOOD PRESSURE BY SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS IN JAPANESE TYPE 2 DIABETES PATIENTS WITH CKD

被引：0

作者：

Kobayashi, Kazuo ^{[1
]}

Tamura, Kouichi ^{[2
]}

Toyoda, Masao ^{[3
]}

Sakai, Hiroyuki ^{[1
]}

Furuki, Takayuki ^{[1
]}

Hatori, Nobuo ^{[1
]}

Sato, Kazuyoshi ^{[1
]}

Miyakawa, Masaaki ^{[1
]}

Kanamori, Akira ^{[1
]}

机构：

[1] Kanagawa Physicians Assoc, Comm Hypertens & Kidney Dis, Yokohama, Kanagawa, Japan

[2] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa, Japan

[3] Tokai Univ, Sch Med, Div Nephrol Endocrinol & Metab, Dept Internal Med, Isehara, Kanagawa, Japan

来源：

JOURNAL OF HYPERTENSION | 2021年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：E211 / E211

页数：1

共 50 条

[1] Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease
Tsukamoto, Shunichiro
Kobayashi, Kazuo
Toyoda, Masao
Hatori, Nobuo
Kanaoka, Tomohiko
Wakui, Hiromichi
Sakai, Hiroyuki
Furuki, Takayuki
Chin, Keiichi
Ito, Shun
Suzuki, Daisuke
Umezono, Tomoya
Aoyama, Togo
Nakajima, Shinichi
Hishiki, Toshimasa
Hatori, Yutaka
Hayashi, Masahiro
Shimura, Hidetoshi
Minagawa, Fuyuki
Mokubo, Atsuko
Takihata, Masahiro
Sato, Kazuyoshi
Miyakawa, Masaaki
Terauchi, Yasuo
Tamura, Kouichi
Kanamori, Akira
HYPERTENSION RESEARCH, 2024, 47 (03) : 628 - 638
[2] Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease
Shunichiro Tsukamoto
Kazuo Kobayashi
Masao Toyoda
Nobuo Hatori
Tomohiko Kanaoka
Hiromichi Wakui
Hiroyuki Sakai
Takayuki Furuki
Keiichi Chin
Shun Ito
Daisuke Suzuki
Tomoya Umezono
Togo Aoyama
Shinichi Nakajima
Toshimasa Hishiki
Yutaka Hatori
Masahiro Hayashi
Hidetoshi Shimura
Fuyuki Minagawa
Atsuko Mokubo
Masahiro Takihata
Kazuyoshi Sato
Masaaki Miyakawa
Yasuo Terauchi
Kouichi Tamura
Akira Kanamori
Hypertension Research, 2024, 47 : 628 - 638
[3] Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes
Fu, Edouard
D'Andrea, Elvira
Wexler, Deborah J.
Patorno, Elisabetta
Paik, Julie M.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 673 - 673
[4] Effect of sodium-glucose cotransporter 2 inhibitors on blood pressure in patients with type 2 diabetes and cardiovascular diseases
Asanuma, Hiroshi
HYPERTENSION RESEARCH, 2024, 47 (09) : 2309 - 2311
[5] Blood Pressure Reduction: An Added Benefit of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes
Majewski, Colleen
Bakris, George L.
DIABETES CARE, 2015, 38 (03) : 429 - 430
[6] Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD
Bakker, Wisanne M.
Gansevoort, Ron T.
Yang, Changyuan
Chertow, Glenn M.
Heerspink, Hiddo J. L.
Vart, Priya
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10): : 1446 - 1449
[7] Prescribing Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with CKD
Zhuo, Min
Li, Jiahua
Mount, David B.
Steele, David J.
Lucier, David J.
Mendu, Mallika L.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 733 - 733
[8] Sodium-glucose cotransporter 2 inhibitors for the management of type 2 diabetes
Siamashvili, Maka
Davis, Stephen N.
EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2181 - 2198
[9] Impact of sodium-glucose cotransporter 2 inhibitors on blood pressure
Reed, James W.
VASCULAR HEALTH AND RISK MANAGEMENT, 2016, 12 : 393 - 405
[10] Influence of Age on the Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Japanese Patients With Type 2 Diabetes Mellitus
Kusunoki, Masataka
Hisano, Fumiya
Matsuda, Shinichi
Wakazono, Naomi
Tsutsumi, Kazuhiko
Miyata, Tetsuro
JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 12 (02) : 53 - 58

← 1 2 3 4 5 →